APVO - Aptevo Therapeutics

-

$undefined

N/A

(N/A)

Aptevo Therapeutics NASDAQ:APVO Aptevo Therapeutics Inc. is a clinical-stage biotechnology company focused on developing novel immunotherapies for the treatment of cancer. The Company's lead clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed based on the Company's versatile and robust ADAPTIR™ modular protein technology platform. The ADAPTIR™ platform is capable of generating highly differentiated bispecific antibodies with unique mechanisms of action for the treatment of different types of cancer.

Location: 2401 4th Ave Ste 1050, Washington, 98121-3460, US | Website: aptevotherapeutics.com | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing


Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

101.3M

Cash

7.753M

Avg Qtr Burn

-5.82M

Short % of Float

0.22%

Insider Ownership

0.03%

Institutional Own.

11.36%

Qtr Updated

09/30/24


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.